Active, Not Recruiting
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
NCT03728361
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +27 more
- Locations
-
- Ohio State University Comprehensive Cancer Center-COHORT 1 Columbus, Ohio, United States
- Ohio State University Comprehensive Cancer Center-COHORT 2 Columbus, Ohio, United States